Band 2
Band 2
About
Provided by Kenneth A Clark
Practice Areas
Ken Clark serves as general counsel to companies and their boards of directors, primarily in the biotechnology industry. Ken has extensive expertise in partnering and strategic transactions, having negotiated more than 100 major strategic alliance and M&A transactions. He also regularly represents companies in financings, spin-outs, and related matters.
Ken served on the firm's board of directors from 2011 to 2014 and from 2002 to 2006, and previously was a member of the firm's Policy Committee. Ken served as a director of Pharmacyclics, Inc. (NASDAQ: PCYC) from 2012 until their sale to AbbVie in 2015.
Chambers Review
USA
Kenneth Clark advises biotechnology businesses on the full span of corporate transactional processes, such as partnerships and strategic alliances, financings and spinouts, and mergers and acquisitions.
Kenneth Clark is frequently called upon to represent life sciences clients in a broad array of corporate transactions including M&A, financings and spinouts.
Discover other Lawyers at
Wilson Sonsini Goodrich & Rosati
California
